Finerenone (Kerendia) significantly reduced urine albumin-to-creatinine ratio (UACR) by 25% from baseline to 6 months compared with the placebo for patients with type 1 …
Copyright MatchingDonors.com©️ 2025 All rights reserved.
Finerenone (Kerendia) significantly reduced urine albumin-to-creatinine ratio (UACR) by 25% from baseline to 6 months compared with the placebo for patients with type 1 …
At the American Heart Association (AHA) 2025 Scientific Sessions in New Orleans, experts emphasized a paradigm shift toward holistic management of patients with type …
Today’s Diabetes News, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.
Copyright MatchingDonors.com©️ 2025 All rights reserved.